Ofloxacin Altan 2 mg/ml solution for infusion EFG

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

Ofloxacino Altan 2 mg/ml solution for infusion EFG

Read the entire leaflet carefully before you start using this medicine, because it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor, pharmacist or nurse.
• This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
• If you experience any side effects, consult your doctor, pharmacist or nurse, even if they are side effects not listed in this leaflet. See section 4.

Leaflet contents:

1. What Ofloxacino Altan is and what it is used for
2. What you need to know before using Ofloxacino Altan
3. How to use Ofloxacino Altan
4. Possible side effects
5. How to store Ofloxacino Altan
6. Contents of the pack and other information

1. What Ofloxacino Altan is and what it is used for

This medicine contains ofloxacin, an antibiotic that belongs to a group called fluoroquinolones. This medicine works by killing the bacteria that cause infections. It is only active against certain strains of bacteria.

This medicinal product is indicated for the treatment of the following infections in adult patients:

• certain urinary tract infections (kidney infections), including certain prostate infections,
• certain genital tract infections in men and women, including cases in which these infections spread into the bloodstream,
• certain bone and joint infections,
• certain respiratory tract infections,
• certain skin infections,
• certain abdominal and hepatic infections,
• in cases of anthrax exposure.

2. What you need to know before using Ofloxacino Altan

If your doctor has informed you of an intolerance to certain sugars, consult them before taking this medicine.

Due to the risk of tendonitis with this medicine, inform your doctor:

• if you are taking corticosteroids for a prolonged period, as they may increase the risk of tendonitis and tendon rupture when used concomitantly with Ofloxacino Altan,
• if you engage in intense physical exercise and/or have a history of tendonitis.

Do not use Ofloxacino Altan

• If you are allergic to ofloxacin, other quinolones, or any of the other components of this medicine (listed in section 6).

Signs of an allergic reaction include: rash, difficulty swallowing or breathing, swelling of the lips, face, throat, or tongue.

• If you have epilepsy or are at risk of seizures.
• If you have previously experienced tendon disorders related to fluoroquinolone administration, which may affect areas such as the wrist or Achilles tendon. A tendon connects muscle to bone.
• If you have a known metabolic disorder called glucose-6-phosphate dehydrogenase deficiency.
• If you are under 18 years of age or still in a growth phase.
• If you are pregnant or breastfeeding (see section “Pregnancy, lactation and fertility”).

Warnings and precautions

Talk to your doctor or pharmacist before using Ofloxacino.

Before starting to use this medicine

Do not use antibacterial medicines containing fluoroquinolones or quinolones, including Ofloxacino, if you have previously experienced a serious adverse reaction to a quinolone or fluoroquinolone. If this applies to you, inform your doctor as soon as possible.

Consult your doctor before starting to use this medicine:

• If you are taking corticosteroids.

• If you have ever had tendonitis.

• If you are over 60 years old.

• If you have any liver or kidney problems, as your treatment may need to be adjusted.

• If you have a heart condition or problems with your heartbeat.

• If you have received an organ transplant.

• If you have or have had neurological problems (including seizures, peripheral neuropathy, or psychiatric disorders).

• If you are taking medicines that may affect the heart or lower blood pressure (see section "Other medicines and Ofloxacino Altan").

• If you or a family member have a history of prolonged QT interval (seen on ECG, the electrical recording of the heart).

• If you have an electrolyte imbalance in the blood (especially low levels of potassium or magnesium in the blood).

• If you have a very slow heart rate (called 'bradycardia').

• If you have a weak heart (heart failure).

• If you have a history of heart attack (myocardial infarction).

• If you are female or elderly.

• If you are taking other medicines that cause abnormal changes in the ECG (see section "Other medicines and Ofloxacino Altan").

• If you have or have had any mental health problems.

• If you have porphyria (a rare disorder affecting metabolism).

• If you are scheduled for surgery under general anesthesia while being treated with Ofloxacino.

• If you suffer from a condition called myasthenia gravis, which causes muscle weakness and excessive muscle fatigue, as this medicine may worsen your condition.

• If you are diabetic and receiving concomitant antidiabetic treatment (oral or insulin injection), as increases or decreases in blood glucose (blood sugar levels), including hypoglycemic coma, have been observed in patients usually treated with antidiabetic agents.

• You or a family member have glucose-6-phosphate dehydrogenase deficiency (G6PD), as you may experience serious blood problems (destruction of red blood cells) when taking this medicine.

• The use of this medicine is not recommended in patients with galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption syndrome (rare hereditary conditions).

• If you have been diagnosed with an enlarged blood vessel or an aneurysm (aortic aneurysm or peripheral large vessel aneurysm). If you have previously experienced aortic dissection (tearing of the aortic wall). If you have been diagnosed with heart valve insufficiency (regurgitation of heart valves).

• If you have a family history of aortic dissection or aneurysm, congenital heart valve disease, or other predisposing risk factors or disorders (e.g., connective tissue disorders such as Marfan syndrome, Ehlers-Danlos syndrome, Turner syndrome, or Sjögren's syndrome (an inflammatory autoimmune disease), or vascular disorders such as Takayasu arteritis, giant cell arteritis, Behçet's disease, hypertension, known atherosclerosis, rheumatoid arthritis (a joint disease), or endocarditis (a heart infection)).

Very rare reports of potentially life-threatening skin rashes (Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis) have been associated with the use of Ofloxacino. Symptoms may include: flu-like symptoms followed by a painful red or purple rash that spreads and forms blisters. If you develop any of the above symptoms, you must stop using the medicine and contact your doctor immediately (see section 4).

The use of Ofloxacino is not recommended if you are suspected of having a MRSA infection.

While being treated with Ofloxacino, avoid exposure to intense sunlight and do not use UV lamps or tanning beds, as your skin may become more sensitive to light.

Contact an ophthalmologist immediately if you experience any changes in vision or any eye problems.

If you experience pain in your fingers or toes while being treated with Ofloxacino, inform your doctor or nurse immediately.

If you are undergoing urine tests, it is important to inform your doctor that you are taking this medicine, as it may alter test results.

If you are unsure whether any of the above cases apply to you, speak with your doctor, pharmacist, or nurse before taking this medicine.

During treatment with this medicine

Inform your doctor immediately if any of the following symptoms occur during treatment with Ofloxacino:

Severe and sudden allergic reaction (anaphylactic reaction/shock). From the first dose, there is a risk of a severe allergic reaction that may present with the following symptoms: chest tightness, dizziness, nausea or fainting, or a feeling of vertigo upon standing. If these symptoms occur, treatment with Ofloxacino must be stopped immediately, as your life could be at risk. Contact your doctor immediately.

Occasionally, joint pain and swelling, or tendon inflammation or rupture, may occur. The risk is higher if you are elderly (over 60 years), have had an organ transplant, have kidney problems, or are taking corticosteroids. Tendon inflammation and rupture may occur within the first 48 hours of treatment and even several months after stopping Ofloxacino. At the first sign of tendon pain or inflammation (e.g., in the ankle, wrist, elbow, shoulder, or knee), stop using Ofloxacino, contact your doctor, and rest the affected area. Avoid unnecessary physical activity, as this may increase the risk of tendon rupture. Be cautious when resuming walking if you have been bedridden for several days due to the risk of tendon rupture. Quinolone antibiotics, to which Ofloxacino belongs, should not be prescribed again.

Rarely, you may experience symptoms of nerve damage (neuropathy) such as pain, burning, tingling, numbness, and/or weakness, especially in the feet and legs or hands and arms. If this occurs, stop using Ofloxacino and inform your doctor immediately to prevent the development of a potentially irreversible disorder.

If you have myasthenia gravis and your condition with respiratory muscle weakness worsens, treatment with Ofloxacino must be stopped and you should contact your doctor immediately.

Diarrhea may occur when taking antibiotics, including Ofloxacino, even several weeks after treatment has ended. If diarrhea becomes severe or persistent, or if you notice blood or mucus in your stool, stop treatment with Ofloxacino immediately, as your life could be at risk. Do not take medications intended to block or slow intestinal transit and contact your doctor.

Inform your doctor or laboratory that you are taking Ofloxacino if you need blood or urine tests (see Interactions with laboratory tests).

Ofloxacino may cause liver problems. If you notice symptoms such as loss of appetite, jaundice (yellowing of the skin and eyes), dark urine, itching, or abdominal tenderness, stop treatment and contact your doctor immediately.

Ofloxacino may reduce the level of white blood cells in the blood and lower your resistance to infections. If you develop an infection with symptoms such as fever and significant deterioration in your general condition, or fever with symptoms of localized infection such as throat/pharynx/mouth pain or urinary problems, seek medical attention immediately. A blood test will be performed to check for a possible reduction in certain white blood cells. It is important to inform your doctor that you are taking this medicine.

Inform your doctor if you or a family member have glucose-6-phosphate dehydrogenase deficiency (G6PD), as you may be at risk of developing anemia with ofloxacin.

If you experience sudden, severe pain in the chest, abdomen, or back, which may be symptoms of aortic dissection or aneurysms, go immediately to an emergency department. The risk may be increased if you are receiving systemic corticosteroid treatment.

If you suddenly develop shortness of breath, especially when lying down, or notice swelling in your ankles, feet, or abdomen, or the onset of palpitations (sensation of rapid or irregular heartbeat), inform your doctor immediately.

Decreased blood sugar levels. This has been reported more frequently in elderly patients, particularly in diabetics. Low blood sugar levels can lead to coma (hypoglycemic coma). Consideration should be given to alternative antibacterial therapy.

If you have epilepsy, you should not take this medicine. If you have another neurological condition, neurological side effects (seizures) may occur. If this happens, stop treatment with Ofloxacino and contact your doctor immediately.

If your vision worsens or you notice any visual problems, inform your doctor and see an ophthalmologist immediately.

Development of blisters with skin peeling, especially in the mouth, eyes, or genitals, which may rapidly spread over the entire body and be life-threatening (Stevens-Johnson Syndrome or Lyell's Syndrome) (see section 4 "Possible adverse effects"). Inform your doctor immediately if skin or mucosal reactions occur. Your skin becomes more sensitive to sunlight and ultraviolet (UV) rays when taking Ofloxacino. During treatment and for up to 48 hours after stopping it, avoid prolonged exposure to sunlight or artificial UV rays, such as tanning lamps.

Severe, disabling, long-lasting, and potentially irreversible adverse effects

Antibacterial medicines containing fluoroquinolones or quinolones, including Ofloxacino, have been associated with very rare but serious adverse effects, some of which were long-lasting (persisting for months or years), disabling, or potentially irreversible. These include tendon, muscle, and joint pain in the upper and lower limbs, difficulty walking, abnormal sensations such as pricking, tingling, pins and needles, numbness, or burning (paresthesia), sensory disturbances such as reduced vision, taste, smell, or hearing, depression, memory loss, severe fatigue, and serious sleep disorders.

If you experience any of these adverse effects after using Ofloxacino, contact your doctor immediately before continuing treatment. You and your doctor will decide whether to continue treatment, considering also the use of an antibiotic from another class.

Interactions with laboratory tests

Urine tests for opiates (used for pain): Ofloxacino may cause false positive results when testing for opiates in urine. If a urine test is performed, inform the doctor that you are taking Ofloxacino.

Tuberculosis tests: Taking Ofloxacino may cause laboratory results for the bacteria causing tuberculosis to be falsely negative.

If you have any questions about the situations described above, consult your doctor or pharmacist.

Children and adolescents

This medicine should not be used in children or adolescents who are still growing.

Other medicines and Ofloxacino Altan

Inform your doctor, pharmacist, or nurse if you are using, have recently used, or might need to use any other medicines, including those obtained without a prescription, homeopathic medicines, herbal remedies, and other health-related products, as it may be necessary to interrupt treatment or adjust the dose of one or more medicines.

Ofloxacino may affect the action of certain medicines, and some medicines may affect the action of Ofloxacino.

Inform your doctor if you are taking the following medicines, as this may influence the occurrence of side effects:

• corticosteroids (used for inflammation). You may be more prone to tendon inflammation and/or rupture;
• oral anticoagulants (to thin the blood). You may be more prone to bleeding. Your doctor will perform blood tests to monitor blood clotting;
• theophylline (used for respiratory problems). You may be more prone to seizures if taking Ofloxacino;
• non-steroidal anti-inflammatory drugs (used for inflammation and pain) such as aspirin, ibuprofen, fenbufen, ketoprofen, indomethacin. You may be more prone to seizures if taking Ofloxacino;
• medicines that may alter heart rhythm, such as those belonging to the antiarrhythmic group (e.g., quinidine, hydroquinidine, disopyramide, amiodarone, sotalol, dofetilide, ibutilide), tricyclic antidepressants, certain antibiotics (macrolide family), or certain antipsychotics;
• probenecid (used for gout), cimetidine (used for gastric ulcers and esophageal burns), furosemide (used for edema), or methotrexate (used especially in certain cancers, psoriasis, rheumatoid arthritis). If you have kidney problems, your doctor will need to adjust the doses.

Inform your doctor if you are taking:

• mycophenolate mofetil (used to prevent organ rejection), as this medicine may become less effective;
• glibenclamide (used to treat diabetes).

Use of Ofloxacino Altan with food and drinks

Do not drink alcohol while taking Ofloxacino, as it may make you feel dizzy or drowsy.

Pregnancy, lactation and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

This medicine should not be administered if you are pregnant or during breastfeeding, as ofloxacin passes into breast milk.

Sports Be cautious of the risk of tendonitis if you engage in intense physical activity (see section on information needed before taking the medicine, "Warnings and precautions").

Driving and use of machines

This medicine may cause dizziness or drowsiness and visual disturbances; therefore, you should not drive or operate machinery while using this medicine.

Ofloxacino Altan contains sodium

This medicine contains 334 mg of sodium (the main component of table/cooking salt) in each 100 ml bag. This corresponds to 16.7% of the maximum daily sodium intake recommended for an adult.

3. How to use Ofloxacino Altan

Your doctor will explain exactly what dose of Ofloxacino Altan you will be given, how often, and for how long. This will depend on the type of infection you have and its severity.

Follow exactly the instructions provided by your doctor for administering this medicine. If in doubt, consult your doctor, pharmacist, or nurse again.

Dosage

In adults

The recommended dose is 400 mg per day, divided into two infusions given 12 hours apart.

In some cases, your doctor may prescribe a higher dose depending on the severity of the infection.

Dosage should be adjusted in patients with renal or hepatic impairment.

Method and route of administration

Injectable route.

This medicine must only be administered intravenously by a SLOW infusion lasting at least 30 minutes for each 200 mg of injectable ofloxacin solution.

Frequency of administration

1 to 2 administrations every 24 hours.

Duration of treatment

For this antibiotic to be effective, it must be used regularly at the prescribed doses and for the length of time indicated by your doctor.

The disappearance of fever or any other symptom does not mean you are completely cured. Any feeling of tiredness is not due to the antibiotic treatment, but to the infection itself. Reducing or stopping your treatment will not affect this feeling and may delay your recovery.

If you use more Ofloxacino Altan than you should

Contact your doctor or pharmacist immediately.

You may be offered monitoring and treatment.

Your doctor will carefully calculate the amount of Ofloxacino Altan to be administered. Therefore, it is unlikely that your doctor or nurse will administer too much of this medicine. However, if you think you have been given too much or too little Ofloxacino Altan, inform your doctor or nurse.

In case of overdose or accidental ingestion, contact your doctor or pharmacist immediately or call the Toxicology Information Service at: 915 620 420, indicating the medicine and the amount taken. It may be necessary to go to a hospital. It is recommended to bring the medicine packaging and leaflet to the healthcare professional.

If you forget to use Ofloxacino Altan

Your doctor or nurse will have instructions on when to administer the medicine. It is unlikely that the medicine will not be administered as prescribed. If you think a dose may have been missed, consult your doctor or nurse.

Do not use a double dose to make up for a missed dose.

If you stop treatment with Ofloxacino Altan

Your doctor will indicate the appropriate dose and duration of treatment with this medicine. Do not stop the treatment early, as this may prevent achieving the desired effect.

If you have any further questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

If you experience any of the side effects as severe, or if you notice any side effect not listed in this leaflet, inform your doctor or nurse.

The following adverse effects have been reported as possible following administration of this medicine:

Common adverse effects (may affect between 1 and 10 in 100 people):

• blockage of a vein due to a blood clot,
• local reactions at the infusion site (pain, redness).

Uncommon adverse effects (may affect between 1 and 10 in 1,000 people):

• fungal infections, antibiotic-resistant germs,
• restlessness, sleep disturbances, difficulty sleeping,
• dizziness, headache,
• eye irritation,
• vertigo,
• cough, nasopharyngitis,
• stomach pain, diarrhea, nausea, vomiting,
• itching, skin rash.

Rare adverse effects (may affect between 1 and 10 in 10,000 people):

• severe allergic reactions (anaphylactic or anaphylactoid reactions, skin swelling) (see section 2 "Warnings and precautions"),
• loss of appetite,
• psychiatric disorders (e.g., unreal visual or auditory perceptions [hallucinations, paranoia], changes in beliefs or thoughts [psychotic reactions] with risk of suicidal thoughts or actions), anxiety, delirium (acute confusional state), nightmares, depression,
• drowsiness, tingling or prickling sensations, taste disturbances, disturbances of the sense of smell,
• vision problems,
• low blood pressure,
• rapid heartbeat,
• breathing difficulties, respiratory discomfort,
• inflammation of the intestine, sometimes with blood,
• increased liver enzymes, elevated bilirubin (substances present in the blood),
• urticaria (rash similar to that caused by nettles), hot flushes, excessive sweating, pustular skin rash,
• tendon inflammation,
• increased serum creatinine (indicator of kidney function),
• low blood sugar levels that may lead to coma (hypoglycaemic coma). This is important for people with diabetes (see section 2 "Warnings and precautions"),
• memory problems.

Very rare adverse effects (may affect less than 1 in 10,000 people):

• decreased number of red blood cells or certain white blood cells (anaemia, leucopenia), high eosinophil concentration, decreased platelets,
• severe allergic reactions (anaphylactic or anaphylactoid shock [sudden swelling of face and neck with breathing difficulty that may be fatal]) (see section 2 "Warnings and precautions"),
• nerve damage in the extremities that may cause motor or sensory disorders (muscle weakness, pain, burning, tingling, numbness) (see section 2 "Warnings and precautions"), seizures, neurological disorders such as resting tremors, rigidity and slow movements, coordination problems,
• ringing in the ears, hearing loss,
• severe and persistent diarrhoea with blood or mucus (see section 2 "Warnings and precautions"),
• jaundice,
• severe skin reactions with blistering, reactions to sunlight or UV rays (see section 2 "Warnings and precautions"), drug rash, bruising or small red spots, inflammation of blood vessels that may cause serious skin damage,
• joint pain, muscle pain, tendon rupture (e.g., Achilles tendon) which may occur within 2 days of starting treatment and affect both sides of the body,
• renal failure.

Frequency not known (cannot be estimated from the available data):

• marked decrease in certain white blood cells,
• bone marrow failure,
• simultaneous decrease in red blood cells, white blood cells and platelets (pancytopenia),
• increased or decreased blood sugar levels (including hypoglycaemic coma), usually in diabetic patients treated with antidiabetic agents (see section 2 "Warnings and precautions"),
• nervousness, psychiatric disorders and depression that may be fatal with suicidal ideation or actions (see section 2 "Warnings and precautions"),
• tremors, uncontrollable movements (dyskinesia), loss of taste (ageusia), fainting (syncope),
• hearing difficulties,
• abnormally rapid heartbeat, irregular rhythm that may be fatal (known as "QT prolongation" on ECG) (see section 2 "Warnings and precautions" and section 3 "How to use Ofloxacino Altan"),
• during ofloxacin infusion, rapid heartbeat and drop in blood pressure, which may be severe in very rare cases,
• lung allergy, severe breathing difficulty,
• difficulty digesting (dyspepsia), gas, constipation and inflammation of the pancreas (pancreatitis),
• severe liver damage; loss of appetite, yellowing of the skin and eyes, dark urine, itching or abdominal pain (may be signs of liver failure, even fatal) (see section 2 "Warnings and precautions"),
• severe skin rashes (Stevens-Johnson syndrome, Lyell syndrome), skin peeling that may spread rapidly and require immediate medical attention, widespread redness with pustules and fever (acute generalised pustular eruption), drug rash, mouth inflammation (stomatitis),
• severe muscle damage, weakness, muscle tear or rupture, ligament rupture, joint disease with pain, swelling and deformity (arthritis),
• worsening of myasthenia gravis (a neuromuscular disorder) (see section 2 "Warnings and precautions"),
• kidney damage,
• attacks of porphyria in patients with this inherited disease,
• moderate increase in liver enzymes (transaminases), exceptionally hepatitis,
• fatigue, fever, pain (including back, chest and limb pain),
• eye inflammation (uveitis),
• skin redness with extensive peeling (exfoliative dermatitis),
• persistent headaches with or without visual disturbances (benign intracranial hypertension).

Ofloxacino Altan may possibly trigger an attack of porphyria (a rare disorder affecting metabolism) in some patients.

Very rare cases of persistent (lasting several months or years) or permanent adverse effects such as tendon inflammation, tendon rupture, joint pain, limb pain, difficulty walking, abnormal sensations such as tingling, prickling, burning, numbness or pain (neuropathy), depression, fatigue, sleep disorders, memory impairment, as well as disturbances in hearing, vision, taste and smell, have been associated with the administration of quinolone and fluoroquinolone antibiotics, sometimes regardless of pre-existing risk factors.

Cases of increased size and weakening or tearing of the aortic wall (aneurysms and dissections), which could lead to rupture and potentially be fatal, and heart valve insufficiency have been reported in patients receiving fluoroquinolones. See also section 2.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor, pharmacist or nurse, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines: https://www.notificaram.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Ofloxacino Altan

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage temperature.

Store in the original packaging to protect it from light and moisture.

Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.

Medicines must not be disposed of via wastewater or household waste. Ask your pharmacist or nurse how to dispose of medicines and packaging that you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of Ofloxacino Altan

• The active substance is ofloxacin. Each ml contains 2 mg of ofloxacin (as hydrochloride).

Each 100 ml contains 200 mg of ofloxacin (as hydrochloride).

• The other components are: sodium chloride, hydrochloric acid, and water for injections.

Appearance of the medicine and contents of the pack

This medicine is presented as a solution for infusion. Each pack contains a poly(vinyl chloride) bag with 100 ml of solution.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder

Altan Pharmaceuticals, S.A.

C/ Cólquide 6, Portal 2, 1st floor, office F. Edificio Prisma
28231 Las Rozas. Madrid (Spain)

Manufacturer

Altan Pharmaceuticals, S.A.
Polígono Industrial de Bernedo s/n
01118 – Álava (Spain)

Date of the most recent review of this leaflet: March 2026

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

---

Public health education advice:

What you should know about antibiotics

Antibiotics are effective in treating infections caused by bacteria. They are not effective against infections caused by viruses.

Your doctor has prescribed this antibiotic because it is appropriate for your specific condition and current illness.

Bacteria can have the ability to survive or reproduce despite the action of an antibiotic. This phenomenon is known as resistance and can render certain antibiotic treatments ineffective.

Antibiotic resistance increases due to the misuse or inappropriate use of antibiotics.

Failure to follow:

• the prescribed dose,
• the timing of administration,
• and the duration of treatment,

may promote the emergence of resistant bacteria, potentially delaying your recovery or even rendering this medicine ineffective.

Therefore, to preserve the effectiveness of this medicine:

1. Use antibiotics only when prescribed by a healthcare professional.
2. Strictly follow the instructions provided in the prescription.
3. Do not reuse an antibiotic without a new medical prescription, even if you believe you are suffering from a similar illness.
4. Never give your antibiotics to another person, as they may not be suitable for their condition.
5. Once treatment is complete, return any unused medicine to your pharmacist for proper and appropriate disposal.